| The Ivy for Friday, September 22, 2023 | | | | | | Market Commentary: Time To Buy This 9.12% Yield Stock? It's rare to find a stock offering a 9%+ yield that doesn't have some murkiness under the hood, but is Medical Properties Trust (NYSE: MPW) that diamond in the rough? We investigate whether this REIT that specializes in leasing healthcare facilities, a segment that has been traditionally regarded as recession-resistant, is worthy of a portfolio spot now. Get the full details here | | | | | |
Ivy Content You May Have Missed | | | | | | Market Commentary: 1 Monthly Income Play You Don't Want To Miss If getting paid passively monthly sounds like something you've been looking for, Realty Income might be just the stock you've been looking for. From a single store 54 years ago, Realty Income is now a true behemoth that rewards investors seeking monthly income. Read the full story here
| | | | | |
| | | | | | Alert: 1 Warren Buffett Stock To Buy Before Takeoff Investment Alert: Buy Coca Cola (KO) Under $59/share Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances. A glance at Berkshire's portfolio will reveal Coca-Cola as one of its heavyweight investments, a position fortified by decades of escalating capital gains. Get the full details here | | | | | |
| | | | | | Alert: 1 Fast Growth Stock To Buy On The Dip Investment Alert: Buy Teladoc (TDOC) Under $23/share Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances. I should lead with the full disclosure that this trade is probably silly. The reason it's such a ludicrous position to consider is the stock is down by, ohhh, probably... Get the full details here | | | | | |
- G. O'Fiachra We value your feedback: Please let us know what you think about our investing ideas so far, and any recommendations you may have for increasing the value of this newsletter. Please follow this link for a quick, 2-minute survey You Might Also Like:  |
|
| | Advertising Disclosure: This email may contain paid advertisements. Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world. We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com. Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here. If you can't see this message, view it in your browser. You are receiving this e-mail at stevenmagallanes520.nims@blogger.com as a part of your free subscription to the Ivy Newsletter. To read our privacy policy follow this link. or To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311 Website: Summa Money Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Copyright 2022 Summa Money. All rights reserved. |
|
|
In order to unsubscribe from this mailing list, please click
here 
No comments:
Post a Comment